Karin Schölin Bywall
Associated researcher at CRB & Senior Lecturer in Publv health at the School of Health, Care and Social Welfare, Division of Public Health Sciences, Mälardalen University.
Karin Schölin Bywall is an associated researcher at CRB and a senior lecturer in public health at Mälardalen University. Her work is mainly focused on advancing public health through research, education, and the implementation of health technologies. She is interested in applying ethical reflections to public health research and education in order to strengthen the evidence base in societal decision-making.
Karin Schölin Bywall holds a PhD from the Faculty of Medicine at Uppsala University (CRB) and a postdoctoral position at CRB. She then started as a researcher in health and welfare technology at Mälardalen University, which led to her current position as a senior lecturer in public health.
Publications
Part of Medical decision making, p. 189-202, 2024
- DOI for Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study?: A Disease Prevention Example in Rheumatoid Arthritis
- Download full text (pdf) of Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study?: A Disease Prevention Example in Rheumatoid Arthritis
Part of BMC Rheumatology, 2023
- DOI for Physical function and severe side effects matter most to patients with RA (< 5 years): a discrete choice experiment assessing preferences for personalized RA treatment
- Download full text (pdf) of Physical function and severe side effects matter most to patients with RA (< 5 years): a discrete choice experiment assessing preferences for personalized RA treatment
Part of BMC Medical Ethics, 2023
- DOI for Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment
- Download full text (pdf) of Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment
Part of Frontiers in Pharmacology, 2023
- DOI for How can patient preferences be used and communicated in the regulatory evaluation of medicinal products?: Findings and recommendations from IMI PREFER and call to action
- Download full text (pdf) of How can patient preferences be used and communicated in the regulatory evaluation of medicinal products?: Findings and recommendations from IMI PREFER and call to action
Part of Patient, p. 641-653, 2023
- DOI for Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
- Download full text (pdf) of Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
Part of BMJ Open, 2023
- DOI for Experiences of individuals with rheumatoid arthritis interacting with health care and the use of a digital self-care application: a qualitative interview study
- Download full text (pdf) of Experiences of individuals with rheumatoid arthritis interacting with health care and the use of a digital self-care application: a qualitative interview study
Part of Clinical Rheumatology, p. 695-704, 2022
- DOI for Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis
- Download full text (pdf) of Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis
Part of Rheumatology, 2022
- DOI for Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
- Download full text (pdf) of Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
Part of BMC Medical Ethics, 2022
- DOI for Would you consider donating your left-over embryos to treat Parkinson’s disease? Interviews with individuals that underwent IVF in Sweden
- Download full text (pdf) of Would you consider donating your left-over embryos to treat Parkinson’s disease? Interviews with individuals that underwent IVF in Sweden
Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis
Part of Scandinavian Journal of Rheumatology, p. 1-11, 2022
Part of BMJ Open, 2022
- DOI for Making space for patients’ preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis
- Download full text (pdf) of Making space for patients’ preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis
Part of Arthritis Research & Therapy, 2022
- DOI for Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
- Download full text (pdf) of Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
Getting a Say: Bringing patients’ views on benefit-risk into medical approvals
2021
Part of BMJ Open, 2021
- DOI for Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project
- Download full text (pdf) of Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project
Part of Patient Education and Counseling, p. 2577-2585, 2021
PhD-supervision
- Adam Ehlert